Medicines Board to probe stem cell ferry plan
The IMB had already begun a probe into the provision of the treatment to multiple sclerosis sufferers from a Carrigaline clinic — but will now expand its inquiry.
Such stem cell treatment is not licensed here as experts say insufficient research has been completed on its effectiveness for MS sufferers.
Lunchtime News
Newsletter
Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.



